WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
US probe of Hondas that can activate emergency braking for no reason moves closer to a recallEthnic Mon groups announce antiThe Rockies have placed Kris Bryant on 10Arakan Army attacks another junta border outpost in western Myanmar — Radio Free AsiaEthnic Mon groups announce antiInside Emma Roberts' $3.6M 'grownSuspects arrested in Arkansas block party shooting that left 1 dead, 9 hurtScottie Scheffler had a quick Masters celebration. Now, it's time to get back to workInside the $95B House package focused on aiding Ukraine, IsraelTwo more endangered ferrets cloned from critter frozen in 1980s
2.8429s , 6502.40625 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,Planet Perspectives news portal